| pubmed-article:9871756 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9871756 | lifeskim:mentions | umls-concept:C0034196 | lld:lifeskim |
| pubmed-article:9871756 | lifeskim:mentions | umls-concept:C0038477 | lld:lifeskim |
| pubmed-article:9871756 | lifeskim:mentions | umls-concept:C0450442 | lld:lifeskim |
| pubmed-article:9871756 | lifeskim:mentions | umls-concept:C0205549 | lld:lifeskim |
| pubmed-article:9871756 | pubmed:issue | 11 | lld:pubmed |
| pubmed-article:9871756 | pubmed:dateCreated | 1999-3-11 | lld:pubmed |
| pubmed-article:9871756 | pubmed:abstractText | SAR for antimicrobial activity against H. pylori was investigated in a new series of 2-alkylguanidino-4-furylthiazoles. Of the compounds obtained, cyclohexylmethyl and ethoxyethyl derivatives were identified as a novel class of anti-H. pylori agents which possessed potent and selective antimicrobial activity against H. pylori. These compounds also showed gastric antisecretory activity. | lld:pubmed |
| pubmed-article:9871756 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9871756 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9871756 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9871756 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9871756 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9871756 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9871756 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9871756 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9871756 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:9871756 | pubmed:issn | 0960-894X | lld:pubmed |
| pubmed-article:9871756 | pubmed:author | pubmed-author:MatsumotoYY | lld:pubmed |
| pubmed-article:9871756 | pubmed:author | pubmed-author:IshikawaHH | lld:pubmed |
| pubmed-article:9871756 | pubmed:author | pubmed-author:KatsuraYY | lld:pubmed |
| pubmed-article:9871756 | pubmed:author | pubmed-author:TakasugiHH | lld:pubmed |
| pubmed-article:9871756 | pubmed:author | pubmed-author:NishinoSS | lld:pubmed |
| pubmed-article:9871756 | pubmed:author | pubmed-author:TomishiTT | lld:pubmed |
| pubmed-article:9871756 | pubmed:author | pubmed-author:SakaneKK | lld:pubmed |
| pubmed-article:9871756 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9871756 | pubmed:day | 2 | lld:pubmed |
| pubmed-article:9871756 | pubmed:volume | 8 | lld:pubmed |
| pubmed-article:9871756 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9871756 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9871756 | pubmed:pagination | 1307-12 | lld:pubmed |
| pubmed-article:9871756 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:9871756 | pubmed:meshHeading | pubmed-meshheading:9871756-... | lld:pubmed |
| pubmed-article:9871756 | pubmed:meshHeading | pubmed-meshheading:9871756-... | lld:pubmed |
| pubmed-article:9871756 | pubmed:meshHeading | pubmed-meshheading:9871756-... | lld:pubmed |
| pubmed-article:9871756 | pubmed:meshHeading | pubmed-meshheading:9871756-... | lld:pubmed |
| pubmed-article:9871756 | pubmed:meshHeading | pubmed-meshheading:9871756-... | lld:pubmed |
| pubmed-article:9871756 | pubmed:meshHeading | pubmed-meshheading:9871756-... | lld:pubmed |
| pubmed-article:9871756 | pubmed:meshHeading | pubmed-meshheading:9871756-... | lld:pubmed |
| pubmed-article:9871756 | pubmed:meshHeading | pubmed-meshheading:9871756-... | lld:pubmed |
| pubmed-article:9871756 | pubmed:meshHeading | pubmed-meshheading:9871756-... | lld:pubmed |
| pubmed-article:9871756 | pubmed:meshHeading | pubmed-meshheading:9871756-... | lld:pubmed |
| pubmed-article:9871756 | pubmed:meshHeading | pubmed-meshheading:9871756-... | lld:pubmed |
| pubmed-article:9871756 | pubmed:meshHeading | pubmed-meshheading:9871756-... | lld:pubmed |
| pubmed-article:9871756 | pubmed:meshHeading | pubmed-meshheading:9871756-... | lld:pubmed |
| pubmed-article:9871756 | pubmed:year | 1998 | lld:pubmed |
| pubmed-article:9871756 | pubmed:articleTitle | Anti-Helicobacter pylori agents. 2. Structure activity relationships in a new series of 2-alkylguanidino-4-furylthiazoles. | lld:pubmed |
| pubmed-article:9871756 | pubmed:affiliation | Medicinal Chemistry Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., Osaka, Japan. | lld:pubmed |
| pubmed-article:9871756 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9871756 | pubmed:publicationType | In Vitro | lld:pubmed |
| http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | pubmed-article:9871756 | lld:chembl |
